Abstract: A wire lock assembly for an access port of an elongate medical tube includes a body having an exterior surface, an interior surface, and a central opening disposed therethrough, an attachment mechanism disposed through the exterior surface of the body, the attachment mechanism having an open end and a closed end, at least one notch arranged on the body and positioned proximate to the central opening and at least one seal supported within the interior surface of the body in communication with the central opening, the seal comprising a passageway therethrough, where the interior surface of the body defines a non-linear pathway for securing one or more medical devices.

Abstract: A medical device includes a handle that includes a first member and a second member. Outer and inner elongate members of the medical device project from a distal end of the first member. The first and second members move, such as rotationally or pivotably move, relative to each other to control relative longitudinal movement of the outer and inner elongate members.

Abstract: A wire lock assembly for an access port of an elongate medical tube includes a body having an exterior surface, an interior surface, and a central opening disposed therethrough, an attachment mechanism disposed through the exterior surface of the body, the attachment mechanism having an open end and a closed end, at least one notch arranged on the body and positioned proximate to the central opening and at least one seal supported within the interior surface of the body in communication with the central opening, the seal comprising a passageway therethrough, where the interior surface of the body defines a non-linear pathway for securing one or more medical devices.

Abstract: A wire lock assembly for an access port of an elongate medical tube includes a body having an exterior surface, an interior surface, and a central opening disposed therethrough, an attachment mechanism disposed through the exterior surface of the body, the attachment mechanism having an open end and a closed end, at least one notch arranged on the body and positioned proximate to the central opening and at least one seal supported within the interior surface of the body in communication with the central opening, the seal comprising a passageway therethrough, where the interior surface of the body defines a non-linear pathway for securing one or more medical devices.

Abstract: A wire lock assembly for an access port of an elongate medical tube includes a body having an exterior surface, an interior surface, and a central opening disposed therethrough, an attachment mechanism disposed through the exterior surface of the body, the attachment mechanism having an open end and a closed end, at least one notch arranged on the body and positioned proximate to the central opening and at least one seal supported within the interior surface of the body in communication with the central opening, the seal comprising a passageway therethrough, where the interior surface of the body defines a non-linear pathway for securing one or more medical devices.

Abstract: A method for the at least partially automatic determination of contact information of at least one communication partner in the context of a communication connection between at least two communication partners in a communication network is proposed, wherein at least one contact information of the communication partner initiating the communication connection is communicated to the at least one receiving communication partner. The at least one contact information is predetermined by the communication partner initiating the communication connection. Furthermore, a terminal for the use in a communication network is provided, preferably a mobile network according to a GSM, GPRS and/or UMTS radio network standard, which terminal is designed and/or adapted to at least partially carry out the method.

Abstract: The invention relates to an active substance combination consisting of clonidine and pramipexole for treating Restless Leg Syndrome.

Abstract: A method for the treatment of Restless Leg Syndrome (RLS), which comprises administering an &agr;2-agonist and a second agent selected from the group consisting of the dopamine agonists, opioids, benzodiazepines and the combination of L-DOPA plus a decarboxylase inhibitor.

Abstract: The invention relates to the use of NK1-receptor antagonists for preparing a pharmaceutical composition for treating Restless Legs Syndrome (RLS) and methods for treating RLS using such compounds.